黑料网 Lineberger member Gary Johnson, PhD, professor and chair of the 黑料网 Department of Pharmacology, has been tapped to join Synodos, a team of scientists working together to defeat the rare genetic disorder neurofibromatosis type 2 (NF2). A first-of-its-kind NF research collaboration, Synodos has brought together centers of excellence from institutions across the country. Johnson will be just one of 12 academic researchers in the collaboration. (excerpt from 黑料网 Lineberger Comprehensive Cancer Center news article by Katie A. Jones, April 11, 2014.)